These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The neuromythology of Parkinson's Disease. Calne DB; Mizuno Y Parkinsonism Relat Disord; 2004 Jul; 10(5):319-22. PubMed ID: 15196512 [TBL] [Abstract][Full Text] [Related]
23. Neurodegenerative disorders and aging. Alzheimer's disease and Parkinson's disease--common ground. Hamill RW; Caine E; Eskin T; Lapham L; Shoulson I; McNeill TH Ann N Y Acad Sci; 1988; 515():411-20. PubMed ID: 3284427 [No Abstract] [Full Text] [Related]
24. Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies. Marek K; Jennings D; Seibyl J Ann Neurol; 2003; 53 Suppl 3():S160-6; discussion S166-9. PubMed ID: 12666107 [No Abstract] [Full Text] [Related]
25. Imaging end points for monitoring neuroprotection in Parkinson's disease. Brooks DJ Ann Neurol; 2003; 53 Suppl 3():S110-8; discussion S118-9. PubMed ID: 12666103 [TBL] [Abstract][Full Text] [Related]
26. [A new history of basal ganglia and physiopathology of Parkinson's disease]. Reinoso Suárez F An R Acad Nac Med (Madr); 2001; 118(4):771-88; discussion 788-92. PubMed ID: 12056254 [TBL] [Abstract][Full Text] [Related]
27. [Etiology and pathogenesis of parkinson's disease]. Mizuno Y; Ikebe S; Mochizuki H; Matumine H; Kondo T No To Shinkei; 1996 Jan; 48(1):5-17. PubMed ID: 8679319 [No Abstract] [Full Text] [Related]
28. Levodopa delivery systems for the treatment of Parkinson's disease: an overview. Goole J; Amighi K Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197 [TBL] [Abstract][Full Text] [Related]
29. Causes of neuronal death in Parkinson's disease. Schapira AH Adv Neurol; 2001; 86():155-62. PubMed ID: 11553973 [TBL] [Abstract][Full Text] [Related]
31. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Hodaie M; Neimat JS; Lozano AM Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250 [TBL] [Abstract][Full Text] [Related]
32. [The status of imaging methods for the treatment of patients with Parkinson's syndrome]. Schwarz J; Gratz S; Hahn U; Förstl H; Jarnig M Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S8-10. PubMed ID: 18437640 [TBL] [Abstract][Full Text] [Related]
33. Transplantation in Parkinson's disease: The future looks bright. Paul G; Ahn YH; Li JY; Brundin P Adv Exp Med Biol; 2006; 557():221-48. PubMed ID: 16955713 [No Abstract] [Full Text] [Related]
34. The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease. Blandini F Funct Neurol; 2001; 16(4 Suppl):99-106. PubMed ID: 11996537 [No Abstract] [Full Text] [Related]
35. Detrimental deletions: mitochondria, aging and Parkinson's disease. Biskup S; Moore DJ Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822 [TBL] [Abstract][Full Text] [Related]
36. The role of iron in the basal ganglion. Youdim MB; Ben-Shachar D; Yehuda S; Riederer P Adv Neurol; 1990; 53():155-62. PubMed ID: 1978513 [No Abstract] [Full Text] [Related]
37. Nursing care of Parkinson's disease. Dick A Elder Care; 1998 Dec-1999 Jan; 10(6):39-42. PubMed ID: 10542498 [No Abstract] [Full Text] [Related]
38. [Parkinson's syndrome. Etiopathogenesis and possibilities of treatment]. Jovicić A Vojnosanit Pregl; 1985; 42(3):206-10. PubMed ID: 3895730 [No Abstract] [Full Text] [Related]
39. [The origin of Parkinson's disease]. Rinne J Duodecim; 1997; 113(18):1819-24. PubMed ID: 10892075 [No Abstract] [Full Text] [Related]
40. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Wichmann T; DeLong MR Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]